Comparison of healthcare utilization among patients treated with alcoholism medications

American Journal of Managed Care

Volumn 16, Issue 12, 2010, Pages 879-888

  Mark, Tami L ^a   Montejano, Leslie B ^b   Kranzler, Henry R ^c   Chalk, Mady ^d   Gastfriend, David R ^e  

^a THOMSON REUTERS   (United Kingdom)

^b THOMSON REUTERS   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^d TREATMENT RESEARCH INSTITUTE   (United States)

^e ALKERMES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; DISULFIRAM; EXTENDED RELEASE NALTREXONE; NALTREXONE; NALTREXONE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ALCOHOLISM; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DRUG COST; FEMALE; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ALCOHOL DETERRENTS; ALCOHOLISM; DELAYED-ACTION PREPARATIONS; DISULFIRAM; FEMALE; HEALTH SERVICES; HEALTH STATUS INDICATORS; HUMANS; INPATIENTS; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; NALTREXONE; NARCOTICS; PROPENSITY SCORE; RETROSPECTIVE STUDIES; TAURINE; UNITED STATES;

EID: 78650936427     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Grant BF, Dawson DA, Stinson FS, Chou SP, Dufour MC, Pickering RP. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug Alcohol Depend. 2004;74(3):223-234.
2. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000 [published correction appears in JAMA. 2005;293(3):293-294, 298]. JAMA. 2004;291(10):1238-1245.
3. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635-2645.
4. National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, US Department of Health and Human Services. Helping patients who drink too much: a clinician's guide. Updated 2005 edition. May 2007. http://pubs.niaaa.nih.gov/publications/Practitioner/CliniciansGuide2005/ clinicians-guide.htm. Accessed December 10, 2009.
5. Mark TL, Kassed CA, Vandivort-Warren R, Levit KR, Kranzler HR. Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. Drug Alcohol Depend. 2009;99(1-3):345-349.
6. Hermos JA, Young MM, Gagnon DR, Fiore LD. Patterns of dispensed disulfiram and naltrexone for alcoholism treatment in a veteran patient population. Alcohol Clin Exp Res. 2004;28(8):1229-1235.
7. Pettinati HM, O'Brien CP, Rabinowitz AR, et al. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychopharmacol. 2006;26(6):610-625.
8. Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O'Brien CP. Naltrexone and alcohol dependence: role of subject compliance. Arch Gen Psychiatry. 1997;54(8):737-742.
9. Kranzler HR, Stephenson JJ, Montejano L, Wang S, Gastfriend DR. Persistence with oral naltrexone for alcohol treatment: implications for health-care utilization. Addiction. 2008;103(11):1801-1808.
10. Harris KM, DeVries A, Dimidjian K. Datapoints: trends in naltrexone use among members of a large private health plan [news column]. Psychiatr Serv. 2004;55(3):221.
11. Mark TL, Swait J. Using stated preference modeling to forecast the effect of medication attributes on prescriptions of alcoholism medications. Value Health. 2003;6(4):474-482.
12. Kranzler HR, Van Kirk J. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin Exp Res. 2001;25(9):1335-1341.
13. Bouza C, Angeles M, Muñoz A, Amate JM. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction. 2004;99(7):811-828.
14. Srisurapanont M, Jarusuraisin N. Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol. 2005;8(2):267-280.
15. Snyder JL, Bowers TG. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials. Am J Drug Alcohol Abuse. 2008;34(4):449-461.
16. Fuller RK, Branchey L, Brightwell DR, et al. Disulfiram treatment of alcoholism: a Veterans Administration cooperative study. JAMA. 1986;256(11):1449-1455.
17. Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA; Veterans Affairs Naltrexone Cooperative Study Group. Naltrexone in the treatment of alcohol dependence. N Engl J Med. 2001;345(24):1734-1739.
18. Anton RF, O'Malley SS, Ciraulo DA, et al; COMBINE Study Research Group. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295(17):2003-2017.
19. Volpicelli JR, Watson NT, King AC, Sherman CE, O'Brien CP. Effect of naltrexone on alcohol "high" in alcoholics. Am J Psychiatry. 1995;152(4):613-615.
20. Mann K, Kiefer F, Spanagel R, Littleton J. Acamprosate: recent findings and future research directions. Alcohol Clin Exp Res. 2008;32(7):1105-1110.
21. Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, US Department of Health and Human Services. Substance abuse treatment advisory: news for the treatment field: naltrexone for extended-release injectable suspension for treatment of alcohol dependence. http://kap.samhsa.gov/products/manuals/pdfs/naltrexone.pdf. Accessed November 5, 2010.
22. De Sousa A, De Sousa A. A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence. Alcohol Alcohol. 2004;39(6):528-531.
23. Magneberg R. The effect of electronic surveillance on alcohol misuse and everyday behavior. Addict Behav. 1998;23(3):281-301.
24. D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol. 1996;49(12):1429-1433.
25. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45(2):197-203.